• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用吲哚菁绿(ICG)对前哨淋巴结进行活检在子宫内膜癌患者中的可行性:一项前瞻性研究。

The Feasibility of Sentinel Lymph-Node, Mapped with Indocyanine Green, Biopsy in Endometrial Cancer Patients: A Prospective Study.

机构信息

Department of Obstetrics and Gynaecology, Medical Academy, Lithuanian University of Health Sciences, LT-44307 Kaunas, Lithuania.

Department of Radiology, Medical Academy, Lithuanian University of Health Sciences, LT-44307 Kaunas, Lithuania.

出版信息

Medicina (Kaunas). 2022 May 26;58(6):712. doi: 10.3390/medicina58060712.

DOI:10.3390/medicina58060712
PMID:35743975
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9227427/
Abstract

Systematic pelvic lymphadenectomy (LND) is an essential part of lymph-node status evaluation in endometrial cancer (EC) patients to tailor the adjuvant treatment. However, it is associated with the post-operative lymphatic complications and does not improve the outcomes of the disease. Indocyanine green (ICG) mapped sentinel lymph-node biopsy (SLB) has recently been introduced into the clinical practice as an alternative for the surgical lymph-node evaluation in EC patients with the potential to decrease LND related complications. The aim of our study was to evaluate the feasibility of ICG mapped SLB in low, intermediate, and high-risk EC patients in a center with no previous experience on endoscopic SLB procedure. : The prospective study was performed. 170 patients with histologically confirmed EC were included. Sentinel lymph-nodes (SLs) were mapped with ICG dye and removed ahead of the total laparoscopic hysterectomy. Low-risk patients received only SLB, while SLB and LND were performed for intermediate and high-risk patients. : The overall detection rate of SLs was 88.8%. Bilateral mapping was achieved in 68.2% of the patients. The overall detection rate for low-risk patients was 93.7%, 85.0% for the intermediate-risk group, and 100% for high-risk patients ( = 0.232). The most common anatomical sites of SLs were the external iliac (45.8% on the right and 46.6% on the left) and obturator regions (20.9% and 25.6%, respectively). Positive lymph-nodes were found in 8 (4.7%) patients. The sensitivity of SLB was 75.0% and negative predictive value (NPV)-97.2%. : Even in the center with no previous experience, sentinel lymph-node biopsy using ICG mapping is feasible. However, the favorable outcomes might be associated with the learning process of newly established method.

摘要

系统盆腔淋巴结清扫术(LND)是评估子宫内膜癌(EC)患者淋巴结状态的重要组成部分,有助于制定辅助治疗方案。然而,LND 与术后淋巴并发症相关,并且不能改善疾病的结局。吲哚菁绿(ICG)示踪前哨淋巴结活检(SLB)最近已被引入临床实践,作为 EC 患者手术淋巴结评估的替代方法,具有降低 LND 相关并发症的潜力。我们的研究目的是评估在一个没有内镜 SLB 经验的中心,ICG 示踪 SLB 在低、中、高危 EC 患者中的可行性。

这是一项前瞻性研究。共纳入 170 例经组织学证实的 EC 患者。使用 ICG 染料对前哨淋巴结(SLs)进行定位,并在全腹腔镜子宫切除术之前进行切除。低危患者仅接受 SLB,而中高危患者则进行 SLB 和 LND。

SLs 的总体检出率为 88.8%。68.2%的患者实现了双侧定位。低危患者的总体检出率为 93.7%,中危组为 85.0%,高危组为 100%(=0.232)。SLs 最常见的解剖部位是髂外(右侧 45.8%,左侧 46.6%)和闭孔区(分别为 20.9%和 25.6%)。8 例(4.7%)患者发现阳性淋巴结。SLB 的灵敏度为 75.0%,阴性预测值(NPV)为 97.2%。

即使在没有既往经验的中心,使用 ICG 映射的前哨淋巴结活检也是可行的。然而,良好的结果可能与新建立的方法的学习过程有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e19f/9227427/c7c86151c836/medicina-58-00712-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e19f/9227427/e04fed41c96b/medicina-58-00712-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e19f/9227427/c23a4eb0f341/medicina-58-00712-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e19f/9227427/038c3808f73f/medicina-58-00712-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e19f/9227427/c7c86151c836/medicina-58-00712-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e19f/9227427/e04fed41c96b/medicina-58-00712-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e19f/9227427/c23a4eb0f341/medicina-58-00712-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e19f/9227427/038c3808f73f/medicina-58-00712-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e19f/9227427/c7c86151c836/medicina-58-00712-g004.jpg

相似文献

1
The Feasibility of Sentinel Lymph-Node, Mapped with Indocyanine Green, Biopsy in Endometrial Cancer Patients: A Prospective Study.应用吲哚菁绿(ICG)对前哨淋巴结进行活检在子宫内膜癌患者中的可行性:一项前瞻性研究。
Medicina (Kaunas). 2022 May 26;58(6):712. doi: 10.3390/medicina58060712.
2
A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study.比较前哨淋巴结活检与淋巴结切除术用于子宫内膜癌分期的研究(FIRES 试验):一项多中心、前瞻性、队列研究。
Lancet Oncol. 2017 Mar;18(3):384-392. doi: 10.1016/S1470-2045(17)30068-2. Epub 2017 Feb 1.
3
A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging.机器人辅助子宫内膜癌分期时荧光成像探测前哨淋巴结的前瞻性研究。
Am J Obstet Gynecol. 2016 Jul;215(1):117.e1-7. doi: 10.1016/j.ajog.2015.12.046. Epub 2015 Dec 29.
4
Indocyanine green fluorescence imaging of lymph nodes during robotic-assisted laparoscopic operation for endometrial cancer. A prospective validation study using a sentinel lymph node surgical algorithm.机器人辅助腹腔镜子宫内膜癌手术中淋巴结的吲哚菁绿荧光成像。一项使用前哨淋巴结手术算法的前瞻性验证研究。
Gynecol Oncol. 2016 Dec;143(3):479-483. doi: 10.1016/j.ygyno.2016.10.029. Epub 2016 Oct 21.
5
An Extraordinary Location of Sentinel Lymph Nodes in a Patient with Endometrial Cancer.子宫内膜癌患者前哨淋巴结的特殊位置。
J Minim Invasive Gynecol. 2023 Aug;30(8):613-614. doi: 10.1016/j.jmig.2023.04.012. Epub 2023 May 1.
6
Anatomical Distribution of Sentinel Lymph Nodes Harvested by Retroperitoneal vNOTES in 34 Consecutive Patients With Early-Stage Endometrial Cancer: Analysis of 124 Lymph Nodes.34 例早期子宫内膜癌患者经腹膜后 vNOTES 采集的前哨淋巴结的解剖分布:124 枚淋巴结分析。
J Minim Invasive Gynecol. 2024 May;31(5):438-444. doi: 10.1016/j.jmig.2024.02.007. Epub 2024 Feb 29.
7
Sentinel lymph node biopsy in endometrial cancer-Feasibility, safety and lymphatic complications.子宫内膜癌前哨淋巴结活检——可行性、安全性和淋巴并发症。
Gynecol Oncol. 2018 Mar;148(3):491-498. doi: 10.1016/j.ygyno.2017.12.017. Epub 2017 Dec 20.
8
En Bloc Resection of Sentinel Lymph Nodes with the Hysterectomy Specimen in Endometrial Cancer.在子宫内膜癌中,与子宫切除术标本一并切除前哨淋巴结。
Ann Surg Oncol. 2024 Jul;31(7):4576-4577. doi: 10.1245/s10434-024-15234-8. Epub 2024 Apr 13.
9
Comparing carbon nanoparticles and indocyanine green for sentinel lymph node mapping in endometrial cancer: A randomized-controlled single-center trial.比较碳纳米颗粒与吲哚菁绿用于子宫内膜癌前哨淋巴结 mapping:一项随机对照单中心试验。 (注:这里“mapping”可结合语境灵活处理,比如“定位”等)
J Surg Oncol. 2023 Aug;128(2):332-343. doi: 10.1002/jso.27268. Epub 2023 Apr 7.
10
Technetium-99m-indocyanine green versus technetium-99m-methylene blue for sentinel lymph node biopsy in early-stage endometrial cancer.锝-99m 吲哚菁绿与锝-99m 甲叉蓝用于早期子宫内膜癌前哨淋巴结活检。
Int J Gynecol Cancer. 2020 Mar;30(3):311-317. doi: 10.1136/ijgc-2019-000923. Epub 2020 Jan 27.

引用本文的文献

1
Risk factors associated with false negative rate of sentinel lymph node biopsy in endometrial cancer: a systematic review and meta-analysis.子宫内膜癌前哨淋巴结活检假阴性率的相关危险因素:一项系统评价和荟萃分析
Front Oncol. 2024 Apr 3;14:1391267. doi: 10.3389/fonc.2024.1391267. eCollection 2024.

本文引用的文献

1
Role of sentinel lymph node biopsy for gynecologic cancers.前哨淋巴结活检在妇科癌症中的作用。
Curr Opin Obstet Gynecol. 2022 Feb 1;34(1):15-19. doi: 10.1097/GCO.0000000000000766.
2
Risk factors for lymphedema and method of assessment in endometrial cancer: a prospective longitudinal multicenter study.子宫内膜癌淋巴水肿的危险因素及评估方法:一项前瞻性纵向多中心研究。
Int J Gynecol Cancer. 2021 Nov;31(11):1416-1427. doi: 10.1136/ijgc-2021-002890. Epub 2021 Oct 5.
3
Impact of lymphadenectomy and lymphoedema on health-related quality of life 1 year after surgery for endometrial cancer. A prospective longitudinal multicentre study.
子宫内膜癌手术后1年淋巴结清扫术和淋巴水肿对健康相关生活质量的影响。一项前瞻性纵向多中心研究。
BJOG. 2022 Feb;129(3):450-460. doi: 10.1111/1471-0528.16870. Epub 2021 Sep 7.
4
NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021.美国国立综合癌症网络(NCCN)指南见解:子宫肿瘤,2021年第3版
J Natl Compr Canc Netw. 2021 Aug 1;19(8):888-895. doi: 10.6004/jnccn.2021.0038.
5
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.ESGO/ESTRO/ESP 指南:子宫内膜癌患者管理
Radiother Oncol. 2021 Jan;154:327-353. doi: 10.1016/j.radonc.2020.11.018.
6
Sentinel lymph node mapping with indocyanine green compared to blue dye tracer in gynecologic malignancies-A single center experience of 218 patients.前哨淋巴结活检中吲哚菁绿与蓝染料示踪剂在妇科恶性肿瘤中的应用:218 例单中心经验。
J Surg Oncol. 2021 Mar;123(4):1092-1098. doi: 10.1002/jso.26338. Epub 2020 Dec 17.
7
Assessment of Sentinel Lymph Node Biopsy vs Lymphadenectomy for Intermediate- and High-Grade Endometrial Cancer Staging.评估前哨淋巴结活检与淋巴结切除术在中高危子宫内膜癌分期中的应用。
JAMA Surg. 2021 Feb 1;156(2):157-164. doi: 10.1001/jamasurg.2020.5060.
8
Laparoscopic sentinel node mapping with intracervical indocyanine green injection for endometrial cancer: the SENTIFAIL study - a multicentric analysis of predictors of failed mapping.腹腔镜下宫颈内注射吲哚菁绿示踪子宫内膜癌前哨淋巴结:SENTIFAIL 研究——失败映射预测因素的多中心分析。
Int J Gynecol Cancer. 2020 Nov;30(11):1713-1718. doi: 10.1136/ijgc-2020-001724. Epub 2020 Aug 31.
9
Comparison between laparoscopic and robotic surgery for sentinel lymph node mapping in endometrial cancer using indocyanine green and near infra-red fluorescence imaging.腹腔镜和机器人手术在使用吲哚菁绿和近红外荧光成像的子宫内膜癌前哨淋巴结定位中的比较。
J Obstet Gynaecol. 2021 May;41(4):642-646. doi: 10.1080/01443615.2020.1789953. Epub 2020 Aug 19.
10
Pelvic Sentinel lymph node detection in High-Risk Endometrial Cancer (SHREC-trial)-the final step towards a paradigm shift in surgical staging.高危型子宫内膜癌中盆腔前哨淋巴结检测(SHREC 试验)-手术分期范式转变的最后一步。
Eur J Cancer. 2019 Jul;116:77-85. doi: 10.1016/j.ejca.2019.04.025. Epub 2019 Jun 7.